A Review Article on Etiology, Clinical Presentation, Laboratory Evaluation and Treatment of Autoimmune Hemolytic Anemia

Jamil Ahmad^1*, Faryal Gohar², Zeyd Merenkov³, Fazal Ghafar⁴ and Altaf Hussain⁵

Abstract

Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. Nevertheless, autoimmune hemolytic anemia (AIHA) should consider in the differential diagnosis of hemolytic anemia whenever patient has an accompanying lymphoproliferative disorder, autoimmune disease, viral or mycoplasma infection. AIHA is further categorized as warm AIHA, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, mixed-type and drug-induced AIHA.  It is the characteristic of the autoantibodies which are accountable for various clinical entities. Diagnosis is based on clinical presentation and work up of AIHA. This review discusses epidemiology, causes, clinical presentation, and laboratory workup and treatment options available for AIHA.

Keywords

etiology; clinical presentation; laboratory evaluation; autoimmune hemolytic anemia

Cite This Article

Ahmad, J., Gohar, F., Merenkov, Z., Ghafar, F., Hussain, A. (2022). A Review Article on Etiology, Clinical Presentation, Laboratory Evaluation and Treatment of Autoimmune Hemolytic Anemia. International Journal of Scientific Advances (IJSCIA), Volume 3| Issue 5: Sep-Oct 2022, Pages 744-749, URL: https://www.ijscia.com/wp-content/uploads/2022/09/Volume3-Issue5-Sep-Oct-No.343-744-749.pdf

Volume 3 | Issue 5: Sep-Oct 2022